Artemis Investment Management LLP Bio Xcel Therapeutics, Inc. Transaction History

Artemis Investment Management LLP

$6.56 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$6.39 - $28.58 $552,249 - $2.47 Million	-86,424 Reduced 8.81%	895,048 $5.96 Million
Q1 2023 May 05, 2023	SELL	$17.7 - $33.24 $6.23 Million - $11.7 Million	-352,219 Reduced 26.41%	981,472 $18.3 Million
Q4 2022 Jan 25, 2023	SELL	$10.25 - $22.43 $418,251 - $915,256	-40,805 Reduced 2.97%	1,333,691 $0
Q3 2022 Oct 25, 2022	SELL	$11.19 - $17.89 $116,845 - $186,807	-10,442 Reduced 0.75%	1,374,496 $16.3 Million
Q2 2022 Jul 22, 2022	SELL	$9.03 - $21.55 $390,908 - $932,899	-43,290 Reduced 3.03%	1,384,938 $18.3 Million
Q1 2022 Apr 21, 2022	BUY	$15.0 - $22.83 $267,690 - $407,424	17,846 Added 1.27%	1,428,228 $29.9 Million
Q4 2021 Feb 08, 2022	BUY	$20.12 - $35.09 $606,054 - $1.06 Million	30,122 Added 2.18%	1,410,382 $28.7 Million
Q3 2021 Oct 26, 2021	BUY	$23.84 - $32.03 $4.46 Million - $5.99 Million	186,970 Added 15.67%	1,380,260 $41.9 Million
Q2 2021 Aug 04, 2021	BUY	$29.06 - $38.83 $4.69 Million - $6.27 Million	161,426 Added 15.64%	1,193,290 $34.7 Million
Q1 2021 Apr 28, 2021	BUY	$39.04 - $64.6 $718,960 - $1.19 Million	18,416 Added 1.82%	1,031,864 $44.4 Million
Q4 2020 Jan 26, 2021	BUY	$42.46 - $56.58 $498,480 - $664,249	11,740 Added 1.17%	1,013,448 $46.8 Million
Q3 2020 Oct 29, 2020	BUY	$37.44 - $64.63 $11.2 Million - $19.4 Million	300,210 Added 42.8%	1,001,708 $43.4 Million
Q2 2020 Jul 27, 2020	SELL	$17.62 - $58.71 $1.51 Million - $5.02 Million	-85,460 Reduced 10.86%	701,498 $37.3 Million
Q1 2020 Apr 14, 2020	SELL	$12.26 - $41.14 $3.51 Million - $11.8 Million	-286,633 Reduced 26.7%	786,958 $17.4 Million
Q4 2019 Jan 14, 2020	SELL	$4.05 - $14.61 $472,201 - $1.7 Million	-116,593 Reduced 9.8%	1,073,591 $15.5 Million
Q3 2019 Oct 10, 2019	BUY	$7.04 - $11.77 $1.49 Million - $2.49 Million	211,169 Added 21.57%	1,190,184 $8.37 Million
Q2 2019 Jul 24, 2019	BUY	$8.99 - $11.79 $90,223 - $118,324	10,036 Added 1.04%	979,015 $10.6 Million
Q1 2019 May 15, 2019	SELL	$3.49 - $10.47 $677,178 - $2.03 Million	-194,034 Reduced 16.68%	968,979 $9.67 Million
Q4 2018 Feb 12, 2019	SELL	$2.41 - $7.61 $221,334 - $698,902	-91,840 Reduced 7.32%	1,163,013 $4.5 Million
Q3 2018 Nov 09, 2018	BUY	$7.51 - $12.99 $122,848 - $212,490	16,358 Added 1.32%	1,254,853 $9.7 Million
Q2 2018 Aug 08, 2018	BUY	$7.02 - $11.26 $196,981 - $315,955	28,060 Added 2.32%	1,238,495 $11.4 Million
Q1 2018 May 10, 2018	BUY	$9.83 - $11.03 $11.9 Million - $13.4 Million	1,210,435 New	1,210,435 $12.2 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Account